UnitedHealth Group Inc. (NYSE:UNH) shares are trading lower on Tuesday after Sen. Elizabeth Warren called for breaking up major healthcare conglomerates, naming UnitedHealth alongside CVS Health Corp. (NYSE:CVS) and The Cigna Group (NYSE:CI), as federal regulators separately proposed tougher healthcare fraud prevention measures.
- UnitedHealth Group shares are sliding. What’s weighing on UNH shares?
Warren Targets Healthcare Conglomerates
Warren said healthcare giants “take a cut at every step” and argued it is time to break up “Big Medicine.” Her comments focused on vertical integration, where companies own health insurers, pharmacy benefit managers (PBMs) and pharmacies under one corporate umbrella.
She cited the Break Up Big Medicine Act, introduced with Sen. Josh Hawley (R-Mo.), which would prohibit health insurers, PBMs and wholesale drug distributors from owning or controlling healthcare providers.
Warren has also criticized UnitedHealth’s $3.3 billion acquisition of Amedisys, arguing it could increase the insurer’s influence over patient care and healthcare costs. The Justice Department’s settlement of its challenge to the deal required the sale of 164 locations across 19 states.
CMS Proposes New Healthcare Fraud Rules
Separately, the Centers for Medicare & Medicaid Services (CMS) proposed its Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) rule, targeting fraud, waste and abuse across Medicare, Medicaid, CHIP and the Health Insurance Marketplace.
The proposal could save taxpayers nearly $90 billion over 10 years, according to CMS. It would strengthen provider screening, improve fraud reporting, increase ownership transparency and give regulators additional authority to deny or revoke provider enrollment.
The proposal also seeks tighter oversight of Medicare Advantage plans and stronger enforcement against agents and brokers involved in abusive Marketplace enrollment practices.
UNH Price Action
UNH Price Action: United Health shares were down about 3.84% at $396.26 at the time of publication on Tuesday, according to Benzinga Pro. The stock traded down to $390.21 on Tuesday before bouncing back slightly.
Image : Shutterstock.com
Recent Comments